Global Pricing Architect – Germany & Developed Markets

Argenx; Zürich; Presencial; CHF 190 000 - 260 000; Tempo integral

Resumo da oferta

argenx, a fast-growing immunology company in Zurich, seeks a Global Pricing Director to shape pricing for launches and lifecycle opportunities across markets. You will partner across access, finance, regulatory and country teams to balance value, patient access and commercial goals.

The role emphasizes robust, evidence-based pricing strategies, international reference pricing considerations and long-term price sustainability in a complex biopharma landscape.

Qualificações

• Proven pricing strategy experience for global launches.
• Experience with HTA markets and reimbursement environments.
• Ability to translate strategy into actionable pricing plans.
• Strong stakeholder management and senior leadership influence.
• Knowledge of international reference pricing and pricing governance.

Responsabilidades

• Lead global pricing strategies for launches, assets and lifecycle opportunities across indications.
• Define launch pricing frameworks and price corridors to support value and access.
• Translate global strategy into actionable policies for regional teams.
• Drive alignment and embed pricing decisions into launch readiness and execution.
• Collaborate with country teams to align local pricing with global principles.
• Assess International Reference Pricing risks and cross-market interdependencies.
• Develop pricing assumptions and scenario analyses with forecasting teams.
• Contribute to business cases for launch decisions and access strategies.

Conhecimentos

Global pricing

Market access

International Reference Pricing

Launch pricing

Stakeholder management

Pricing governance

Analytical capability

Strategic execution

Formação académica

Advanced graduate degree in life sciences, medicine, business, finance or health economics

Descrição da oferta de emprego

argenx, a fast-growing immunology company in Zurich, seeks a Global Pricing Director to shape pricing for launches and lifecycle opportunities across markets. You will partner across access, finance, regulatory and country teams to balance value, patient access and commercial goals.

The role emphasizes robust, evidence-based pricing strategies, international reference pricing considerations and long-term price sustainability in a complex biopharma landscape.